[go: up one dir, main page]

GB202007377D0 - Composition - Google Patents

Composition

Info

Publication number
GB202007377D0
GB202007377D0 GBGB2007377.1A GB202007377A GB202007377D0 GB 202007377 D0 GB202007377 D0 GB 202007377D0 GB 202007377 A GB202007377 A GB 202007377A GB 202007377 D0 GB202007377 D0 GB 202007377D0
Authority
GB
United Kingdom
Prior art keywords
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2007377.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Wolverhampton
Original Assignee
University of Wolverhampton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Wolverhampton filed Critical University of Wolverhampton
Priority to GBGB2007377.1A priority Critical patent/GB202007377D0/en
Publication of GB202007377D0 publication Critical patent/GB202007377D0/en
Priority to GB2217264.7A priority patent/GB2612201A/en
Priority to PCT/GB2021/051187 priority patent/WO2021234362A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GBGB2007377.1A 2020-05-19 2020-05-19 Composition Ceased GB202007377D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB2007377.1A GB202007377D0 (en) 2020-05-19 2020-05-19 Composition
GB2217264.7A GB2612201A (en) 2020-05-19 2021-05-18 Topical disulfiram for treating viral infections
PCT/GB2021/051187 WO2021234362A1 (en) 2020-05-19 2021-05-18 Topical disulfiram for treating viral infections

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2007377.1A GB202007377D0 (en) 2020-05-19 2020-05-19 Composition

Publications (1)

Publication Number Publication Date
GB202007377D0 true GB202007377D0 (en) 2020-07-01

Family

ID=71135339

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB2007377.1A Ceased GB202007377D0 (en) 2020-05-19 2020-05-19 Composition
GB2217264.7A Withdrawn GB2612201A (en) 2020-05-19 2021-05-18 Topical disulfiram for treating viral infections

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB2217264.7A Withdrawn GB2612201A (en) 2020-05-19 2021-05-18 Topical disulfiram for treating viral infections

Country Status (2)

Country Link
GB (2) GB202007377D0 (en)
WO (1) WO2021234362A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113304131B (en) * 2020-02-26 2022-10-18 上海科技大学 Application of polyphenol substances in resisting coronavirus
US12226431B2 (en) * 2021-09-11 2025-02-18 Porosome Therapeutics, Inc. Aerosol and topical administration of a formulation containing cyclodextrin, quercetin and zinc, in combination or separately, to mitigate infection by enveloped viruses
TW202207909A (en) * 2020-06-16 2022-03-01 中國醫藥大學 Use of disulfiram for treating infection of sars-cov-2
IL301183A (en) * 2020-09-14 2023-05-01 Philip Morris Products Sa A pharmaceutical preparation containing hydroxychloroquine and its uses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106377496A (en) * 2016-11-19 2017-02-08 诺马（北京）科技有限公司 Anti-cancer transdermic absorption preparation

Also Published As

Publication number Publication date
GB2612201A (en) 2023-04-26
GB202217264D0 (en) 2023-01-04
WO2021234362A1 (en) 2021-11-25

Similar Documents

Publication Publication Date Title
EP4256011C0 (en) Composition
GB202005911D0 (en) Composition
GB202004460D0 (en) Herbical composition
GB202018029D0 (en) Composition
GB202007377D0 (en) Composition
GB202105455D0 (en) Composition
GB202103439D0 (en) Composition
GB202016236D0 (en) Composition
GB202012895D0 (en) Composition
GB202006093D0 (en) Composition
GB202103434D0 (en) Composition
GB202000619D0 (en) Composition
EP4330363C0 (en) Composition
EP4259762C0 (en) Composition
GB202104498D0 (en) Composition
GB202014635D0 (en) Composition
GB202003550D0 (en) Composition
GB202406302D0 (en) Composition
GB202116333D0 (en) Composition
GB202109550D0 (en) Composition
EP4176034C0 (en) Composition
GB202108511D0 (en) Composition
GB202107377D0 (en) Composition
GB202107382D0 (en) Composition
GB202105744D0 (en) Composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)